Breaking News Instant updates and real-time market news.

AKRX

Akorn

$3.93

-0.01 (-0.25%)

07:58
01/09/19
01/09
07:58
01/09/19
07:58

Akorn receives FDA warning letter related to Illinois manufacturing facility

Akorn announced that it received a warning letter from the FDA related to an inspection of its Decatur, Illinois manufacturing facility in April and May of 2018. Akorn will continue to work collaboratively with the FDA to resolve all issues addressed in the warning letter. The company will respond to the FDA letter within the required 15 working days. The company has full confidence in the quality of the products manufactured at the Decatur facility and expects to continue production at the plant.

AKRX Akorn
$3.93

-0.01 (-0.25%)

11/26/18
RBCM
11/26/18
NO CHANGE
RBCM
Sector Perform
Akorn gets FDA approval for generic Voltaren Gel, says RBC Capital
RBC Capital analyst Randall Stanicky said his "back and forth with management" at Akorn confirmed that the company received FDA approval for its generic version of Voltaren Gel, which the analyst notes represents the third ANDA approval from the company's Amityville facility since October. Stanicky, who continues to watch the company's ongoing litigation as well as its progress on the remediation of its Decatur and Somerset facilities, keeps a Sector Perform rating on Akorn shares.
11/27/18
PIPR
11/27/18
NO CHANGE
Target $9
PIPR
Overweight
Akorn approval an 'encouraging development,' says Piper Jaffray
Piper Jaffray analyst David Amsellem views Akorn's (AKRX) approval of its generic of Voltaren Gel as an "encouraging development." The news demonstrates that the company can execute on the approval of products on the more technically challenging end of the generics spectrum, Amsellem tells investors in a research note. The analyst believes Akorn is well positioned for "significant EBITDA recovery" over the next two years. He sees a "high likelihood" that the company in 2018 will have worked through the bulk of the erosion of key generics due to competition and a "relatively high" probability of meaningful cost reductions if it loses its appeal in its case against Fresenius (FSNUY). Amsellem reiterates an Overweight rating on Akorn with a $9 price target.
12/07/18
CHLM
12/07/18
NO CHANGE
Target $11
CHLM
Buy
Craig-Hallum maintains Buy rating, $11 target on Akorn after Fresenius ruling
Craig-Hallum analyst Matt Hewitt said the Delaware Supreme Court ruling in favor of Fresenius (FSNUY) ends any hopes that a merger with Akorn (AKRX) will still occur, which may be a disappointment to some investors. However, it has been his view since the first ruling was announced that Akorn should be valued on a standalone basis. Akorn currently has a large pipeline of higher margin generics and the company's low-cost manufacturing facility in India has been idled due to the terms of the Fresenius agreement, but is likely to be brought online sometime in FY19 or FY20, Hewitt tells investors. He keeps a Buy rating and $11 price target on Akorn shares, which are down $1.34, or 24%, to $4.25 in afternoon trading.
12/10/18
PIPR
12/10/18
NO CHANGE
Target $9
PIPR
Overweight
Piper does not view Akorn as 'major fixer-upper,' keeps $9 target
Piper Jaffray analyst David Amsellem says he would not view Akorn (AKRX) as a "major fixer-upper" now that it is planning to move forward as a stand-alone company. Much of the pressure on EBITDA in recent years was a function of limited-competition products with brand-like margins, Amsellem tells investors in a research note. Further, the rest of Akorn's product portfolio appears to be stable, says the analyst. In addition, "high-quality" abbreviated new drug application approvals have been happening, "and that matters," argues Amsellem. He keeps an Overweight rating on Akorn with a $9 price target.

TODAY'S FREE FLY STORIES

LBY

Libbey

$5.75

0.15 (2.68%)

18:14
02/20/19
02/20
18:14
02/20/19
18:14
Earnings
Libbey sees FY19 revenue increase in low single digits, one estimate $806.6M »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LBY

Libbey

$5.75

0.15 (2.68%)

18:13
02/20/19
02/20
18:13
02/20/19
18:13
Earnings
Libbey reports Q4 EPS (18c), two estimates 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:07
02/20/19
02/20
18:07
02/20/19
18:07
Hot Stocks
NetEase reports Q4 online game service revenues up 37.7% at $1.6B »

Reports Q4 e-commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:05
02/20/19
02/20
18:05
02/20/19
18:05
Hot Stocks
NetEase declares Q4 quarterly dividend of 48c vs 45c in Q3 »

The dividend is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:04
02/20/19
02/20
18:04
02/20/19
18:04
Earnings
NetEase reports Q4 EPS $2.66, consensus $1.54 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

LEE

Lee Enterprises

$2.61

0.01 (0.38%)

18:04
02/20/19
02/20
18:04
02/20/19
18:04
Hot Stocks
Lee Enterprises board approves $10M stock repurchase program »

Lee Enterprises announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNY

Kearny Financial

$13.48

-0.01 (-0.07%)

18:03
02/20/19
02/20
18:03
02/20/19
18:03
Hot Stocks
Kearny Financial raises quarterly dividend to 6c per share from 5c »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$53.43

0.11 (0.21%)

18:02
02/20/19
02/20
18:02
02/20/19
18:02
Earnings
Breaking Earnings news story on Copart »

Copart reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

CE

Celanese

$102.65

1.71 (1.69%)

18:02
02/20/19
02/20
18:02
02/20/19
18:02
Hot Stocks
Celanese raises Acetyl Intermediates price by 5c per lb »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$53.43

0.11 (0.21%)

18:01
02/20/19
02/20
18:01
02/20/19
18:01
Earnings
Copart reports Q2 EPS 55c, consensus 51c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

WPG

Washington Prime

$5.77

(0.00%)

17:50
02/20/19
02/20
17:50
02/20/19
17:50
Earnings
Breaking Earnings news story on Washington Prime »

Washington Prime sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CPA

Copa Holdings

$89.89

-0.8 (-0.88%)

, GE

General Electric

$10.10

-0.03 (-0.30%)

17:49
02/20/19
02/20
17:49
02/20/19
17:49
Hot Stocks
Copa Airlines picks GE Aviation for digital records management »

Copa Airlines (CPA) has…

CPA

Copa Holdings

$89.89

-0.8 (-0.88%)

GE

General Electric

$10.10

-0.03 (-0.30%)

BA

Boeing

$421.61

5.21 (1.25%)

ERJ

Embraer

$20.52

-0.14 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 11

    Mar

  • 12

    Mar

  • 14

    Mar

  • 28

    May

WPG

Washington Prime

$5.77

(0.00%)

17:49
02/20/19
02/20
17:49
02/20/19
17:49
Earnings
Washington Prime reports Q4 AFFO 38c, one estimate 39c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RMAX

RE/MAX Holdings

$40.54

0.11 (0.27%)

17:48
02/20/19
02/20
17:48
02/20/19
17:48
Hot Stocks
RE/MAX Holdings raises quarterly dividend 5% to 21c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 08

    Mar

  • 13

    Mar

MSA

MSA Safety

$100.06

-1.13 (-1.12%)

17:46
02/20/19
02/20
17:46
02/20/19
17:46
Earnings
MSA Safety reports Q4 adjusted EPS $1.27, consensus $1.27 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TFX

Teleflex

$286.65

4.57 (1.62%)

, PINC

Premier

$38.05

-0.03 (-0.08%)

17:31
02/20/19
02/20
17:31
02/20/19
17:31
Hot Stocks
Teleflex awarded SURPASS deal with Premier »

Teleflex (TFX) has been…

TFX

Teleflex

$286.65

4.57 (1.62%)

PINC

Premier

$38.05

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 03

    Mar

  • 06

    Mar

AGI

Alamos Gold

$4.87

0.05 (1.04%)

17:31
02/20/19
02/20
17:31
02/20/19
17:31
Earnings
Alamos Gold reports Q4 adjusted EPS 1c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NTR

Nutrien

$54.43

1.075 (2.02%)

17:30
02/20/19
02/20
17:30
02/20/19
17:30
Hot Stocks
Nutrien intends to renew share repurchase program »

Nutrien announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 27

    Feb

AKRX

Akorn

$4.03

-0.42 (-9.44%)

, FSNUY

Fresenius SE

$0.00

(0.00%)

17:28
02/20/19
02/20
17:28
02/20/19
17:28
Hot Stocks
Akorn 'strongly contests' Fresenius' proposed amended claims »

Akorn, Inc. (AKRX) said…

AKRX

Akorn

$4.03

-0.42 (-9.44%)

FSNUY

Fresenius SE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 01

    May

MESO

Mesoblast

$4.28

0.13 (3.13%)

17:26
02/20/19
02/20
17:26
02/20/19
17:26
Earnings
Mesoblast reports 1H19 $44.1M loss versus 1H18 profit of $6.7M »

In the first half FY2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

KODK

Kodak

$3.03

-0.045 (-1.47%)

17:21
02/20/19
02/20
17:21
02/20/19
17:21
Hot Stocks
Kodak names Jim Continenza executive chairman »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

17:20
02/20/19
02/20
17:20
02/20/19
17:20
Hot Stocks
Macquarie Infrastructure sees FY19 EBITDA $610M-$635M vs. $601.9M last year »

Sees FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

17:19
02/20/19
02/20
17:19
02/20/19
17:19
Earnings
Macquarie Infrastructure reports Q4 adj. EBITDA $152.4M vs. $159.6M last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

17:16
02/20/19
02/20
17:16
02/20/19
17:16
Hot Stocks
Breaking Hot Stocks news story on Cheesecake Factory »

Cheesecake Factory sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 06

    Mar

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

17:16
02/20/19
02/20
17:16
02/20/19
17:16
Earnings
Cheesecake Factory sees Q1 adjusted EPS 58c-62c, consensus 61c »

Guidance taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.